Publication: Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266
Issued Date
2016-01-01
Resource Type
ISSN
18767753
18735061
18735061
Other identifier(s)
2-s2.0-84955139718
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Stem Cell Research. Vol.16, No.1 (2016), 202-205
Suggested Citation
Adele G. Marthaler, Alisa Tubsuwan, Benjamin Schmid, Ulla B. Poulsen, Alexander F. Engelbrecht, Ulrike A. Mau-Holzmann, Poul Hyttel, Troels T. Nielsen, Jørgen E. Nielsen, Bjørn Holst Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266. Stem Cell Research. Vol.16, No.1 (2016), 202-205. doi:10.1016/j.scr.2015.12.048 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/43201
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266
Other Contributor(s)
Abstract
© 2016. Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease primarily affecting the cerebellum. Very little is known about the molecular mechanisms underlying the disease and, to date, no cure or treatment is available. We have successfully generated bona fide induced pluripotent stem cell (iPSC) lines of SCA2 patients in order to study a disease-specific phenotype. Here, we demonstrate the gene correction of the iPSC line H266 clone 10 where we have exchanged the expanded CAG repeat of the ATXN2 gene with the normal length found in healthy alleles. This gene corrected cell line will provide the ideal control to model SCA2 by iPSC technology.